Carregant...
Gender and sex disparity in cancer trials
The study population within phase III clinical trials leading to approval of new cancer agents should ideally more closely mirror the population who will ultimately receive these agents. Although the number of females participating in clinical trials has increased over the past several decades, fema...
Guardat en:
| Publicat a: | ESMO Open |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7440710/ https://ncbi.nlm.nih.gov/pubmed/32816862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000773 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|